Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
N-Nitroso 5-Chloro-2-Nitrodiphenylamine
| CAT No | SRC-N0142675 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Clobazam EP Impurity A
| CAT No | SRC-N0142676 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O3 |
| Mol.Wt. | 315.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Clopidogrel Nitroso Impurity 1
| CAT No | SRC-N0142677 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4S |
| Mol.Wt. | 366.8g/mol |
| INV STATUS | In Stock |
Clopidogrel Nitroso Impurity 2
| CAT No | SRC-N0142678 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4S |
| Mol.Wt. | 366.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Clopidogrel EP Impurity B
| CAT No | SRC-N0142679 |
| CAS No | NA |
| Mol.F. | C15H15ClN2O3S |
| Mol.Wt. | 338.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Clopidogrel Open Ring R-Enantiomer
| CAT No | SRC-N0142680 |
| CAS No | NA |
| Mol.F. | C15H15ClN2O3S |
| Mol.Wt. | 338.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity D
| CAT No | SRC-N0142681 |
| CAS No | NA |
| Mol.F. | C17H23N3O5 |
| Mol.Wt. | 349.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity E
| CAT No | SRC-N0142682 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity F
| CAT No | SRC-N0142683 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity H
| CAT No | SRC-N0142684 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity C
| CAT No | SRC-N0142685 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso 3,4-O,O-Dimethyl Carbidopa
| CAT No | SRC-N0142686 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity J
| CAT No | SRC-N0142687 |
| CAS No | NA |
| Mol.F. | C10H12BrN3O5 |
| Mol.Wt. | 334.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa Hydantoic Acid
| CAT No | SRC-N0142688 |
| CAS No | NA |
| Mol.F. | C13H17N3O6 |
| Mol.Wt. | 311.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa Impurity 2
| CAT No | SRC-N0142689 |
| CAS No | NA |
| Mol.F. | C10H13N3O4 |
| Mol.Wt. | 239.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Carbidopa EP/BP Impurity I
| CAT No | SRC-N0142690 |
| CAS No | NA |
| Mol.F. | C10H12BrN3O5 |
| Mol.Wt. | 334.13 g/mol |
| INV STATUS | In Stock |